Biosimilar Solutions Initiates Registrational Clinical
Biosimilar Solutions, Inc. will set up a facility in Aguadilla in OcyonBio's Campus in Puerto Rico to support the production of BSC0826....
Stay updated with breaking news from Biosimilar Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biosimilar Solutions, Inc. will set up a facility in Aguadilla in OcyonBio's Campus in Puerto Rico to support the production of BSC0826....
Last week, OcyonBio announced a manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. in Puerto Rico. According to the...
Biosimilar Solutions, Inc. expects to complete the clinical study in 2022...
Share this article Share this article SAN JUAN, Puerto Rico, Feb. 3, 2021 /PRNewswire/ -- In line with its mission of promoting investment and economic development in the Island, economic development organization Invest Puerto Rico ("InvestPR"), revealed two major successes for its bioscience sector. CytoImmune Therapeutics, Inc. and Biosimilar Solutions, LLC, each committed to establishing operations on the Island to develop their biotechnology products. Invest Puerto Rico elevates the Island’s role as a global bioscience R&D and manufacturing hub attracting two major life-critical i...